AbCellera Biologics (Long hold)

NASDAQ:ABCL   AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, Artificial Intelligence-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development.

Imagine a world where artificial intelligence could find the cure to any disease. That's what this company is all about.

the chart might not be the prettiest, but their mission is one I am willing to invest in.


$37 is my conservative target from the current levels, and it's very possible we make a few more lower lows, but ultimately I think this company has a very bright future despite the recent beat downs.

If and when we reach $37, I'd like to re-evaluate my analysis, & deep dive into the wave structure which brought us there. If it looks clean, then new projections can be made.



The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.